BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Takara Bio USA Holdings, Inc. Announces the Acquisition of Curio Bioscience, Adding Spatial Biology to Its Broad Portfolio of Single-Cell Omics Solutions

  January 16, 2025

   · 

  3 min read
• Press Releases

  Handa Therapeutics Acquires FDA Approved Chronic Myeloid Leukemia Drug, PHYRAGO (dasatinib) Tablets

  January 16, 2025

   · 

  3 min read
• Press Releases

  Chromatin Bioscience’s synthetic promoter supports EsoBiotec’s ESO-T01 CAR-T therapy as it enters the clinic

  January 16, 2025

   · 

  4 min read
• Press Releases

  RID Launches a One-Button Solution for Microbiology Testing That Provides Pathogen ID and Antibiotic Sensitivity in 5 Hours

  January 16, 2025

   · 

  2 min read
• Press Releases

  Silver Bullet Therapeutics Announces FDA Approval of Pre-Market Study

  January 16, 2025

   · 

  4 min read
• Press Releases

  Serina Therapeutics Announces Sale of UniverXome Subsidiary

  January 16, 2025

   · 

  5 min read
• Press Releases

  Alcresta Therapeutics Announces FDA Expanded Use Clearance for RELiZORB® (iMMOBILIZED LIPASE) Cartridge for Pediatric Patients 1 Year of Age and Older

  January 16, 2025

   · 

  3 min read
• Press Releases

  Santhera Pharmaceuticals Provides Update on Royalty Agreement for AGAMREE® (Vamorolone) and Warrants held by Idorsia

  January 16, 2025

   · 

  6 min read
• Press Releases

  Outlook Therapeutics® Announces Complete Twelve Week Efficacy and Safety Results of NORSE EIGHT Clinical Trial

  January 16, 2025

   · 

  12 min read
• Press Releases

  Merck to Hold Fourth-Quarter and Full-Year 2024 Sales and Earnings Conference Call Feb. 4

  January 16, 2025

   · 

  3 min read